These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6324701)

  • 61. Hyperosmolality due to antacid treatment.
    Faraj JH
    Anaesthesia; 1989 Nov; 44(11):911-2. PubMed ID: 2556946
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Alginate improves symptom control].
    Siegmund-Schultze N
    MMW Fortschr Med; 2016 Jun; 158(11):76. PubMed ID: 27271425
    [No Abstract]   [Full Text] [Related]  

  • 63. [The experience of usage of alginate contain medication in complex therapy at children with GERD disease].
    Shcherbakov PL; Lobanov IuF; Fugol DS; Shilova AV
    Eksp Klin Gastroenterol; 2009; (5):81-4. PubMed ID: 20201310
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Management of reflux oesophagitis.
    Hamill JJ
    Practitioner; 1983 Apr; 227(1378):637-9. PubMed ID: 6304672
    [No Abstract]   [Full Text] [Related]  

  • 65. [A successful treatment of gastro-oesophageal reflux in infancy with Gaviscon].
    Gross-Kieselstein E; Branski D; Abrahamov A
    Harefuah; 1975 Oct; 89(7):327-9. PubMed ID: 171200
    [No Abstract]   [Full Text] [Related]  

  • 66. Sugar-free prescriptions.
    Glenwright HD; Shaw L; Cooke C
    Br Dent J; 1988 Jan; 164(1):6. PubMed ID: 3422162
    [No Abstract]   [Full Text] [Related]  

  • 67. Rinsing with antacid suspension reduces hydrochloric acid-induced erosion.
    Alves Mdo S; Mantilla TF; Bridi EC; Basting RT; França FM; Amaral FL; Turssi CP
    Arch Oral Biol; 2016 Jan; 61():66-70. PubMed ID: 26519789
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative study of Algicon suspension and magnesium trisilicate mixture in the treatment of reflux dyspepsia of pregnancy.
    Lang GD; Dougall A
    Br J Clin Pract Suppl; 1989 Feb; 66():48-51; discussion 61-4. PubMed ID: 2556175
    [No Abstract]   [Full Text] [Related]  

  • 69. [Side effects of antacids].
    Leopolder-Ochsendorf A; Holtermüller KH
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1216-9. PubMed ID: 2990844
    [No Abstract]   [Full Text] [Related]  

  • 70. Treatment of reflux oesophagitis.
    Wesdorp IC
    Scand J Gastroenterol Suppl; 1982; 79():106-19. PubMed ID: 6131532
    [No Abstract]   [Full Text] [Related]  

  • 71. Amphojeloma: antacid impaction in a critically ill patient.
    Girotti MJ; Ruddan J; Cohanim M
    Can J Surg; 1984 Jul; 27(4):379-80, 382. PubMed ID: 6744146
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Diagnostic value of alginate test in gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Droxzdov VN; Firsova LD; Kozhurina TS
    Eksp Klin Gastroenterol; 2010; (12):102-7. PubMed ID: 21560632
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Influence of sodium alginate on the intestinal transit in low birth weight newborn infants].
    Chouraqui JP; Morer I; Renard P; Bielsky MC; Richard-Berthe C; Rambaud P
    Pediatrie; 1993; 48(6):473-7. PubMed ID: 8247649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Post-prandial reflux suppression by a raft-forming alginate (Gaviscon Advance) compared to a simple antacid documented by magnetic resonance imaging and pH-impedance monitoring: mechanistic assessment in healthy volunteers and randomised, controlled, double-blind study in reflux patients.
    Sweis R; Kaufman E; Anggiansah A; Wong T; Dettmar P; Fried M; Schwizer W; Avvari RK; Pal A; Fox M
    Aliment Pharmacol Ther; 2013 Jun; 37(11):1093-102. PubMed ID: 23600790
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon® Advance: how we do it.
    Lieder A; Issing W
    Clin Otolaryngol; 2011 Dec; 36(6):583-7. PubMed ID: 22212545
    [No Abstract]   [Full Text] [Related]  

  • 76. Commentary: revisiting the past--does it hold the key to the future treatment of refractory GERD?
    Katz PO; Schnoll-Sussman F
    Aliment Pharmacol Ther; 2013 Jul; 38(2):202-3. PubMed ID: 23772900
    [No Abstract]   [Full Text] [Related]  

  • 77. Echo-planar magnetic resonance imaging of Gaviscon alginate rafts in-vivo.
    Marciani L; Little SL; Snee J; Coleman NS; Tyler DJ; Sykes J; Jolliffe IG; Dettmar PW; Spiller RC; Gowland PA
    J Pharm Pharmacol; 2002 Oct; 54(10):1351-6. PubMed ID: 12396296
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.
    Jones R; Franklin K; Spicer R; Berry J
    Lancet; 1995 Aug; 346(8973):499. PubMed ID: 7543641
    [No Abstract]   [Full Text] [Related]  

  • 79. Magnesium load induced by ingestion of magnesium-containing antacids.
    Lembcke B; Fuchs C
    Contrib Nephrol; 1984; 38():185-94. PubMed ID: 6713895
    [No Abstract]   [Full Text] [Related]  

  • 80. Commentary: revisiting the past--does it hold the key to the future treatment of refractory GERD? Author's reply.
    Fox M
    Aliment Pharmacol Ther; 2013 Jul; 38(2):203-4. PubMed ID: 23772901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.